Literature DB >> 33373380

Acquisition, prevalence and clearance of type-specific human papillomavirus infections in young sexually active Indian women: A community-based multicentric cohort study.

Richard Muwonge1, Partha Basu1, Tarik Gheit2, Devasena Anantharaman3, Yogesh Verma4, Neerja Bhatla5, Smita Joshi6, Pulikottil O Esmy7, Usha Rani Reddy Poli8, Anand Shah9, Eric Zomawia10, Surendra S Shastri11, Sharmila Pimple12, Priya R Prabhu3, Sanjay Hingmire13, Aruna Chiwate13, Catherine Sauvaget1, Eric Lucas1, Sylla G Malvi13, Maqsood Siddiqi14, Subha Sankaran3, Thiraviam Pillai Rameshwari Ammal Kannan3, Rintu Varghese3, Uma Divate6, Shachi Vashist5, Gauravi Mishra12, Radhika Jadhav6, Massimo Tommasino2, M Radhakrishna Pillai3, Rengaswamy Sankaranarayanan15, Kasturi Jayant15.   

Abstract

In context of the ongoing multi-centric HPV vaccine study in India, unvaccinated married women (N = 1484) aged 18-23 years were recruited in 2012-2015 as age-matched controls to the vaccinated women and followed up yearly. We assess type-specific prevalence, natural history and potential determinants of human papillomavirus (HPV) infection in these unvaccinated women. Cervical samples were collected yearly for at least four consecutive years. A Multiplex Type-Specific E7-Based polymerase chain reaction assay was used to detect 21 HPV types. HPV prevalence was 36.4% during 6 years. Most common HPV types were 16 (6.5%) and 31 (6.1%). Highest persistence were observed for HPV 35 (62.5%) and 52 (25%). New HPV acquisition rate was 5.6/1000 person-months of observation (PMO), highest for HPV 16 (1.1/1000 PMO). Type-specific clearance rates ranged between 2.9-5.5/100 PMO. HPV 16 and/or 18 infections were 41% (95% CI 4-63%) lower among women with 2-<3 years between marriage and first cervical sample collection compared to those with <2 years. HPV prevalence and acquisition rates in young Indian women were lower than their Western counterparts. HPV 16 infections being most common shows the importance and potential impact of HPV vaccination in India. Women with 2-3 years exposure had reduced risk possibly due to higher infections clearance.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33373380      PMCID: PMC7771682          DOI: 10.1371/journal.pone.0244242

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  29 in total

1.  High prevalence of oncogenic HPV-16 in cervical smears of asymptomatic women of eastern Uttar Pradesh, India: a population-based study.

Authors:  Shikha Srivastava; Sadhana Gupta; Jagat Kumar Roy
Journal:  J Biosci       Date:  2012-03       Impact factor: 1.826

2.  Prevalence of high--risk human papillomavirus infections in women with benign cervical cytology: a hospital based study from North India.

Authors:  R Aggarwal; S Gupta; R Nijhawan; V Suri; A Kaur; V Bhasin; S K Arora
Journal:  Indian J Cancer       Date:  2006 Jul-Sep       Impact factor: 1.224

3.  Comparison of hybrid capture II, linear array, and a bead-based multiplex genotyping assay for detection of human papillomavirus in women with negative pap test results and atypical squamous cells of undetermined significance.

Authors:  Manola Comar; Michelle R Iannacone; Giorgia Casalicchio; Sandrine McKay-Chopin; Massimo Tommasino; Tarik Gheit
Journal:  J Clin Microbiol       Date:  2012-10-03       Impact factor: 5.948

4.  A 2-year prospective study of human papillomavirus persistence among women with a cytological diagnosis of atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion.

Authors:  Martyn Plummer; Mark Schiffman; Philip E Castle; Delphine Maucort-Boulch; Cosette M Wheeler
Journal:  J Infect Dis       Date:  2007-04-16       Impact factor: 5.226

5.  Prevalence of high-risk HPV and associated risk factors in cases of cervical carcinoma in Tamil Nadu, India.

Authors:  Krishnakumar Vinodhini; Santhanam Shanmughapriya; Sumathy Sanmugham; Ganesan Senthikumar; Bhudev C Das; Kalimuthusamy Natarajaseenivasan
Journal:  Int J Gynaecol Obstet       Date:  2012-09-15       Impact factor: 3.561

6.  Comparison of Two Widely Used Human Papillomavirus Detection and Genotyping Methods, GP5+/6+-Based PCR Followed by Reverse Line Blot Hybridization and Multiplex Type-Specific E7-Based PCR.

Authors:  Gary M Clifford; Salvatore Vaccarella; Silvia Franceschi; Vanessa Tenet; M Chantal Umulisa; Ugyen Tshomo; Bolormaa Dondog; Alex Vorsters; Massimo Tommasino; Daniëlle A M Heideman; Peter J F Snijders; Tarik Gheit
Journal:  J Clin Microbiol       Date:  2016-05-25       Impact factor: 5.948

7.  Papillomavirus infection in rural women in southern India.

Authors:  S Franceschi; R Rajkumar; P J F Snijders; A Arslan; C Mahé; M Plummer; R Sankaranarayanan; J Cherian; C J L M Meijer; E Weiderpass
Journal:  Br J Cancer       Date:  2005-02-14       Impact factor: 7.640

8.  Higher prevalence of human papillomavirus infection in adolescent and young adult girls belonging to different Indian tribes with varied socio-sexual lifestyle.

Authors:  Kirti Sharma; Atul Kathait; Asha Jain; Karmila Kujur; Shirish Raghuwanshi; Alok Chandra Bharti; Asha Chandola Saklani; Bhudev Chandra Das
Journal:  PLoS One       Date:  2015-05-08       Impact factor: 3.240

9.  Two-dose recommendation for Human Papillomavirus vaccine can be extended up to 18 years - updated evidence from Indian follow-up cohort study.

Authors:  Partha Basu; Richard Muwonge; Neerja Bhatla; Bhagwan M Nene; Smita Joshi; Pulikottil O Esmy; Usha Rani Reddy Poli; Geeta Joshi; Yogesh Verma; Eric Zomawia; Surendra S Shastri; Sharmila Pimple; Devasena Anantharaman; Priya R Prabhu; Sanjay Hingmire; Catherine Sauvaget; Eric Lucas; Michael Pawlita; Tarik Gheit; Kasturi Jayant; Sylla G Malvi; Maqsood Siddiqi; Angelika Michel; Julia Butt; Subha Sankaran; Thiraviam Pillai Rameshwari Ammal Kannan; Rintu Varghese; Uma Divate; Martina Willhauck-Fleckenstein; Tim Waterboer; Martin Müller; Peter Sehr; Shachi Vashist; Gauravi Mishra; Radhika Jadhav; Ranjit Thorat; Massimo Tommasino; M Radhakrishna Pillai; Rengaswamy Sankaranarayanan
Journal:  Papillomavirus Res       Date:  2019-01-31

10.  Immunogenicity and HPV infection after one, two, and three doses of quadrivalent HPV vaccine in girls in India: a multicentre prospective cohort study.

Authors:  Rengaswamy Sankaranarayanan; Priya Ramesh Prabhu; Michael Pawlita; Tarik Gheit; Neerja Bhatla; Richard Muwonge; Bhagwan M Nene; Pulikottil Okuru Esmy; Smita Joshi; Usha Rani Reddy Poli; Parimal Jivarajani; Yogesh Verma; Eric Zomawia; Maqsood Siddiqi; Surendra S Shastri; Kasturi Jayant; Sylla G Malvi; Eric Lucas; Angelika Michel; Julia Butt; Janki Mohan Babu Vijayamma; Subha Sankaran; Thiraviam Pillai Rameshwari Ammal Kannan; Rintu Varghese; Uma Divate; Shila Thomas; Geeta Joshi; Martina Willhauck-Fleckenstein; Tim Waterboer; Martin Müller; Peter Sehr; Sanjay Hingmire; Alka Kriplani; Gauravi Mishra; Sharmila Pimple; Radhika Jadhav; Catherine Sauvaget; Massimo Tommasino; Madhavan Radhakrishna Pillai
Journal:  Lancet Oncol       Date:  2015-12-02       Impact factor: 41.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.